| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 83,800 | 420,100 | 156,600 | 45,400 | | Cost of Revenue |
-
|
-
|
-
|
-
| | | Gross Profit |
-
| 420,100 | 156,600 | 45,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 95,100 | 110,900 | 74,900 | 85,500 | | Non Recurring |
-
| (23,900) | 23,900 |
-
| | Others |
-
| 167,400 |
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 136,300 | 165,700 | 57,800 | (40,100) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| (600) | | Earnings Before Interest And Taxes | 156,100 | 165,700 | 57,800 | (40,700) | | Interest Expense | 6,600 | 6,700 | 6,500 | 6,000 | | Income Before Tax | 149,500 | 159,000 | 51,300 | (46,700) | | Income Tax Expense | 2,000 |
-
| (1,000) | 1,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 147,500 | 159,000 | 52,300 | (47,700) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 147,500 | 159,000 | 52,300 | (47,700) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $147,500 | $159,000 | $52,300 | ($47,700) |
|
0.32% Nasdaq 
0.54%
Income Statement
